Newcomers tend to arrive with the same handful of myths, each a collapsed distinction: more is better (imports a full-dose mindset), natural = safe (origin is not a risk profile), legal = safe (different systems, different questions), mechanism = proof (plausibility is not demonstration), [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 and “it worked for them” = it works (a report is not an outcome). [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 Each is corrected here and routed to the material that handles it. The through-line: the controlled evidence is limited, [3] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 and most of these errors come from treating enthusiasm as data. [4] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Education-only. Not medical advice. Correcting a myth is not endorsing the practice; it is clearing the ground for accurate understanding.
Corrections and routing, not instruction. Each myth points you to the part of the library that answers it properly.
Five myths, corrected and routed
| Myth | Why it’s wrong | Routes to |
|---|---|---|
| More is better | A microdose is sub-perceptual by definition; scaling up changes the thing | What to understand first |
| Natural = safe | Origin says nothing about risk | Safety |
| Legal = safe | Law and evidence are different systems | Legality is not safety |
| Mechanism = proof | Plausibility is not demonstration | What the mechanism shows |
| ”Worked for them” = it works | A report is not an outcome | Setting realistic expectations |
| Protocol means proven | Structure is not validation | Protocols |
| Lower dose means no risk | Risk changes, it does not disappear | Safety |
More is not better
“If a little helps, more will help more” imports a full-dose dose-response mindset into a practice defined by being sub-perceptual. Scaling a microdose up does not make a better microdose; it makes a different thing, with a different effect and risk profile. The assumptions that hold for ordinary dose-response do not transfer.
Natural is not safe
Natural and safe are simply unrelated. Plenty of natural substances are toxic, and being a mushroom says nothing about contraindications, interactions, or vulnerability. The naturalness of psilocybin describes its origin, not its safety, which is decided by evidence about risk and assessed with a clinician.
Legal is not safe, and mechanism is not proof
Legality is set by a political and regulatory system; safety and efficacy are set by evidence — so a legal substance can still carry real risk. [5] Observational Psychedelics not linked to mental health problems or suicidal behavior: A population study doi:10.1177/0269881114568039 Likewise, psilocin’s action on serotonin receptors is real, [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 but a mechanism shows only that a benefit is possible; demonstration requires controlled outcomes, which remain limited. [3] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 Treating a mechanism as proof borrows the authority of real science for a conclusion it has not reached.
”It worked for them” is not “it works”
A friend’s success is a single report shaped by expectation, context, and individual factors — and expectation alone can produce such improvements. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 It is a reason to investigate, not evidence the compound caused it or that it will repeat for you. Reports are hypotheses; outcomes need controls.
Two more to clear
“A protocol makes it proven.” A protocol provides structure, and structure is not validation. A schedule can be common in reports or used as a research design without being shown superior, effective, or appropriate for any individual; the Protocols material describes such schedules as referenced research, never as proof.
“A lower dose means no risk.” Lower acute intensity is not zero risk. A sub-perceptual dose may reduce perceptual effects, but it does not remove medication interactions, psychological vulnerability, long-term uncertainty, or legal risk.
- Collapsed distinctions
- Each myth collapses one of the four distinctions. [4] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
- Natural ≠ safe
- Origin is not a risk profile.
- Mechanism ≠ proof
- Plausibility is not demonstrated efficacy. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478
- Report ≠ outcome
- One person’s result does not generalise or prove cause. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878
Frequently asked questions
Isn't more always better, so a slightly bigger dose would work better?
No — that reasoning imports a full-dose mindset into a sub-perceptual practice. A microdose is defined by being below the threshold of noticeable effect; scaling it up does not make it a better microdose, it makes it a different thing entirely, with a different risk and effect profile. The dose-response assumptions that hold elsewhere do not transfer, and treating microdosing as a dial to turn up is one of the clearest beginner errors.
Mushrooms are natural, so aren't they safe?
No. Natural and safe are unrelated. Many natural substances are toxic or carry real risks, and being a mushroom says nothing about contraindications, interactions, or individual vulnerability. The naturalness of psilocybin tells you about its origin, not its safety profile. Safety is a question for the safety material and a clinician, decided by evidence about risk — never inferred from the word natural.
If it is legal somewhere, doesn't that mean it is safe?
No. Legality and safety are decided by entirely different systems — one political and regulatory, the other evidential. A substance can be permitted in a setting and still carry real risks, just as familiar legal substances do. Legal status tells you how a jurisdiction treats something at a point in time; it is not a verdict on physiological or psychological risk. The legal-status material treats this confusion in full.
There's a clear mechanism, so doesn't that prove it works?
No. A mechanism shows that an effect is biologically plausible, not that it occurs. Psilocin’s action on serotonin receptors is real and well described, [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 but plausibility is not demonstration — only controlled outcome studies can show a benefit, and for microdosing those remain limited. [3] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 Treating a mechanism as proof is perhaps the most common sophisticated-sounding error, because it borrows the authority of real science for a conclusion the science has not reached.
It worked for my friend, so won't it work for me?
Not necessarily, and the reasoning skips several steps. Your friend’s experience is a single report shaped by their expectations, context, and individual factors, and controlled work shows expectation alone can produce such improvements. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 What worked for one person, even genuinely, does not establish that the compound caused it or that it generalises to you. A report is not an outcome — treat a friend’s success as a reason to investigate, not as evidence it will repeat.